Saudi Arabia has been named as the world’s largest market for diabetes, with a quarter of the population now battling the condition according to a new WHO survey.
The World Health Organisation report shows that Diabetes is now becoming a modern day epidemic in the Desert Kingdom, with unhealthy diets and a lack of exercise leading to rates soaring.
Even more concerningly it’s estimated 13% of people with type-2 Diabetes remain undiagnosed, putting them at a far greater risk of developing heart disease, kidney issues and a problems with their vision.
New techniques that go beyond simply lowering glucose levels are now being looked at, with a focus also placed on lowering blood pressure and stabilising weight loss.
Speaking about the opening of a three day educational program focused on the issue, Chairman of the Saudi Scientific Diabetes Society, Professor Abdulrahman Al Sheikh, said: “Early combination therapy with Dapagliflozin and Metformin is an appropriate treatment option that enables those with T2 Diabetes to achieve individualized glycaemic goals, either as initial combination therapy in treatment-naive patients or as Dapagliflozin add-on in patients inadequately controlled with Metformin therapy.”
Are you an Endorcrinologist who could help Saudi Arabia in its battle with Diabetes? Register on our website today for job alerts.
A life changing move could be far closer than you might imagine.